483 Sun Pharmaceutical Industries Sep 2012

483 Sun Pharmaceutical Industries Sep 2012

Michael Charles FDA, Gayle Lawson FDA, Sarah Mcmullen FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Mohali, India facility and issued inspectional observations (via FDA 483) on 26 Sep 2012.

Add To Cart

Product details

  • Category: Human Drugs
  • Inspection end: 26 Sep 2012
  • Location: Mohali, India